BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33462410)

  • 1. mTORC1 and mTORC2 coordinate early NK cell development by differentially inducing E4BP4 and T-bet.
    Li D; Wang Y; Yang M; Dong Z
    Cell Death Differ; 2021 Jun; 28(6):1900-1909. PubMed ID: 33462410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mTORC1 and mTORC2 differentially promote natural killer cell development.
    Yang C; Tsaih SW; Lemke A; Flister MJ; Thakar MS; Malarkannan S
    Elife; 2018 May; 7():. PubMed ID: 29809146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mTORC1 and mTORC2 play different roles in regulating cardiomyocyte differentiation from embryonic stem cells.
    Zheng B; Wang J; Tang L; Shi J; Zhu D
    Int J Dev Biol; 2017; 61(1-2):65-72. PubMed ID: 28287249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of mTORC1 and mTORC2 in controlling γδ T1 and γδ T17 differentiation and function.
    Yang Q; Liu X; Liu Q; Guan Z; Luo J; Cao G; Cai R; Li Z; Xu Y; Wu Z; Xu M; Zhang S; Zhang F; Yang H; Lin X; Yang M; Wu Y; Gao Y; Flavell R; Hao J; Yin Z
    Cell Death Differ; 2020 Jul; 27(7):2248-2262. PubMed ID: 32001780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Full Activation of Kinase Protein Kinase B by Phosphoinositide-Dependent Protein Kinase-1 and Mammalian Target of Rapamycin Complex 2 Is Required for Early Natural Killer Cell Development and Survival.
    He J; Zhao J; Quan Y; Hou X; Yang M; Dong Z
    Front Immunol; 2020; 11():617404. PubMed ID: 33633735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mTORC1 and mTORC2 regulate skin morphogenesis and epidermal barrier formation.
    Ding X; Bloch W; Iden S; Rüegg MA; Hall MN; Leptin M; Partridge L; Eming SA
    Nat Commun; 2016 Oct; 7():13226. PubMed ID: 27807348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosstalks between mTORC1 and mTORC2 variagate cytokine signaling to control NK maturation and effector function.
    Wang F; Meng M; Mo B; Yang Y; Ji Y; Huang P; Lai W; Pan X; You T; Luo H; Guan X; Deng Y; Yuan S; Chu J; Namaka M; Hughes T; Ye L; Yu J; Li X; Deng Y
    Nat Commun; 2018 Nov; 9(1):4874. PubMed ID: 30451838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential roles and activation of mammalian target of rapamycin complexes 1 and 2 during cell migration in prostate cancer cells.
    Venugopal SV; Caggia S; Gambrell-Sanders D; Khan SA
    Prostate; 2020 Apr; 80(5):412-423. PubMed ID: 31995655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mTORC2 Loss in Oligodendrocyte Progenitor Cells Results in Regional Hypomyelination in the Central Nervous System.
    Dahl KD; Almeida AR; Hathaway HA; Bourne J; Brown TL; Finseth LT; Wood TL; Macklin WB
    J Neurosci; 2023 Jan; 43(4):540-558. PubMed ID: 36460463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapamycin and mTORC2 inhibition synergistically reduce contraction-stimulated muscle protein synthesis.
    Ogasawara R; Knudsen JR; Li J; Ato S; Jensen TE
    J Physiol; 2020 Dec; 598(23):5453-5466. PubMed ID: 32893874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mTORC2 acts as a gatekeeper for mTORC1 deficiency-mediated impairments in ILC3 development.
    Deng YF; Wu ST; Peng HY; Tian L; Li YN; Yang Y; Meng M; Huang LL; Xiong PW; Li SY; Yang QL; Wang LL; Li XY; Li LP; Lu XL; Li XH; Wei YL; Xiao ZH; Yu JH; Deng YC
    Acta Pharmacol Sin; 2023 Nov; 44(11):2243-2252. PubMed ID: 37407703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transcription factor E4bp4/Nfil3 controls commitment to the NK lineage and directly regulates Eomes and Id2 expression.
    Male V; Nisoli I; Kostrzewski T; Allan DS; Carlyle JR; Lord GM; Wack A; Brady HJ
    J Exp Med; 2014 Apr; 211(4):635-42. PubMed ID: 24663216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mTORC1 activity is essential for erythropoiesis and B cell lineage commitment.
    Malik N; Dunn KM; Cassels J; Hay J; Estell C; Sansom OJ; Michie AM
    Sci Rep; 2019 Nov; 9(1):16917. PubMed ID: 31729420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NK cell development requires Tsc1-dependent negative regulation of IL-15-triggered mTORC1 activation.
    Yang M; Chen S; Du J; He J; Wang Y; Li Z; Liu G; Peng W; Zeng X; Li D; Xu P; Guo W; Chang Z; Wang S; Tian Z; Dong Z
    Nat Commun; 2016 Sep; 7():12730. PubMed ID: 27601261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-cell transcriptome reveals the novel role of T-bet in suppressing the immature NK gene signature.
    Yang C; Siebert JR; Burns R; Zheng Y; Mei A; Bonacci B; Wang D; Urrutia RA; Riese MJ; Rao S; Carlson KS; Thakar MS; Malarkannan S
    Elife; 2020 May; 9():. PubMed ID: 32406817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective disruption of mTORC1 and mTORC2 in VTA astrocytes induces depression and anxiety-like behaviors in mice.
    Zheng Z; Zhou H; Yang L; Zhang L; Guo M
    Behav Brain Res; 2024 Apr; 463():114888. PubMed ID: 38307148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor-recognized α₂-macroglobulin binds to cell surface-associated GRP78 and activates mTORC1 and mTORC2 signaling in prostate cancer cells.
    Misra UK; Pizzo SV
    PLoS One; 2012; 7(12):e51735. PubMed ID: 23272152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective interference of mTORC1/RAPTOR protects against human disc cellular apoptosis, senescence, and extracellular matrix catabolism with Akt and autophagy induction.
    Ito M; Yurube T; Kakutani K; Maeno K; Takada T; Terashima Y; Kakiuchi Y; Takeoka Y; Miyazaki S; Kuroda R; Nishida K
    Osteoarthritis Cartilage; 2017 Dec; 25(12):2134-2146. PubMed ID: 28888905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting of mTORC2 may have advantages over selective targeting of mTORC1 in the treatment of malignant pheochromocytoma.
    Zhang X; Wang X; Xu T; Zhong S; Shen Z
    Tumour Biol; 2015 Jul; 36(7):5273-81. PubMed ID: 25666752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mTORC1 and mTORC2 regulate insulin secretion through Akt in INS-1 cells.
    Le Bacquer O; Queniat G; Gmyr V; Kerr-Conte J; Lefebvre B; Pattou F
    J Endocrinol; 2013 Jan; 216(1):21-9. PubMed ID: 23092880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.